JBIO

15.3902.19%
AJ

Andrew James King

President of Research & Development

Dr. Andrew James King, DVM, PhD, BVMS, is President of Research & Development of Jade Biosciences, Inc. from April 18, 2026. Dr. King was Chief Scientific Officer & Head of R&D of Jade Biosciences, Inc. from August 2024 to April 18, 2026. He served as the Chief Scientific Officer at Chinook Therapeutics, Inc. since June 2021 until August 11, 2023. He joined Chinook Therapeutics, Inc. in May 2019. He had been the Head of Renal Discovery and Translational Medicine at Chinook Therapeutics, Inc. since May 2019 until June 2021. Prior to Chinook Therapeutics, Inc., he was the Senior Director of Discovery and Translational Biology at Ardelyx. Previously, he had been at AbbVie in roles of increasing responsibility and he led the Renal Discovery scientific strategy to treat chronic kidney disease. He received his Ph.D. Degree in pharmacology and Toxicology from Michigan State University and completed training in Veterinary Medicine and Surgery at Murdoch University in Australia. He holds a B.Sc. in Veterinary Biology from Murdoch University in Australia, a BVMS from Murdoch University in Australia.

Positions